Sanvello
Commercial- Indications
- Depression, Anxiety, Post-traumatic stress disorder, Substance use disorder, Schizophrenia, Attention deficit hyperactivity disorder
Company intelligence / Profile preview
Sanvello Health provides a clinically validated, app-based digital mental health platform focused on stress, anxiety, and depression. Over 60% of self-care users report improvement within 30 days. The app includes self-care tools based on cognitive behavioral therapy (CBT) and mindfulness, as well as access to coaching and teletherapy services. It partners with major insurance payers to offer covered treatment for over 37 million people[3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanvello Health.